化瘀止血法防治急性早幼粒细胞白血病出血和弥漫性血管内凝血疗效观察  

Clinical Observation Huayuzhixue Prevent and Cure the Hemorrhage and DIC followed Acute Promyelocytic Leukemia

作　　者：成玉斌[1] 黄世林[2] 向阳[2] 陈楠楠 孙锋[1] 郭爱霞[2] 

机构地区：[1]解放军总医院军医进修学院,北京100853 [2]解放军第210医院,大连116021 [3]不详

出　　处：《中国中医急症》2008年第1期29-30,共2页Journal of Emergency in Traditional Chinese Medicine

摘　　要：目的探讨化瘀止血防治急性早幼粒细胞白血病(APL)出血和弥漫性血管内凝血(DIC)的临床疗效。方法早期采用丹参注射液或川芎嗪注射液,DIC时采用小剂量肝素钠静滴,并间断输注血浆和血小板治疗合并出血的APL62例。结果合并出血38例中8例进展为DIC,32例DIC中31例治愈,无1例出血倾向加重。结论化瘀止血可降低APLDIC的发生率,提高治愈率。Objective： To investigate the effect of Huayuzhixue prevent and cure the hemorrhage and DIC followed Acute Promyelocytic Leukemia（APL）. Methods： APL patients with hemorrhage were treated with Danshen Injection or ligustrazine injection. Patients with DIC were treated with low - dose heparin. Results： 8 patients changed into DIC in 38 patients with hemorrhage. In 32 patients with DIC, 31 patients were cure. The hemorrhagic tendency did not become more serious in anyone. Conclusion： Huayuzhixue can decrease the DIC incidence accompanied with APL, increase the cure rate.

关 键 词：急性早幼粒细胞白血病 弥漫性血管内凝血 化瘀止血 

分 类 号：R733.71[医药卫生—肿瘤]